Ozempic and Wegovy could potentially aid individuals in smoking cessation

Another study showed that semaglutide (a drug found in Ozempic and Wegovi – It may help treat addiction: Researchers found that people prescribed the drug to treat type 2 diabetes were less likely to seek medical attention for smoking than those taking other diabetes medications.

Semaglutide helps treat obesity and type 2 diabetes by mimicking hormones that suppress appetite and regulate blood sugar levels. Previous studies have also shown that semaglutide reduces the incidence of diabetes. Cannabis Use Disorder and Alcoholism.

To find out the effect of semaglutide on tobacco addiction, Ron Shu Researchers at Case Western Reserve University in Ohio collected data from the electronic medical records of about 223,000 people in the US with type 2 diabetes and smoking habits, about 6,000 of whom had been prescribed semaglutide, and the rest were using one of seven other diabetes medications.

The researchers then tracked whether participants met with a health care provider about smoking or received smoking cessation counseling within a year of starting to take the smoking cessation medication.

After taking into account variables such as age, sex, race and certain health conditions, the team found that people using semaglutide were, on average, less likely to receive tobacco-related medical care than people taking other medications, which the researchers took to be an indication that these people may be more successful in quitting smoking.

For example, semaglutide users were 32% less likely to receive the treatment. Insulin 18% lower than users Metformin user.

People taking semaglutide may be less likely to seek medical care for their smoking, even though they didn’t necessarily stop using such products. But Xu said that because they all sought tobacco-related medical care at similar rates before they started taking type 2 diabetes medication, semaglutide may actually have helped them.

The study was not a randomized controlled trial, which is the highest level of medical evidence, so the results do not conclusively show that semaglutide is behind the effect, he said. Patricia Grigson Kennedy At Pennsylvania State University, however, other studies have shown that semaglutide reduces activity in areas of the brain involved in reward processing and craving, so there may be a causal relationship.